SCHEMBL22929980

SCHEMBL22929980

c1ccc2c(c1)-c1ccccc1-c1cnc(-n3c4ccccc4c4ccccc43)nc1-c1ccccc1-2

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.37
ATM Q13315 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
DUSP3 P51452 1/20 0.35
CDK5 Q00535 2/20 0.34
CDK5R1 Q15078 2/20 0.34
MKNK1 Q9BUB5 1/20 0.32
MKNK2 Q9HBH9 1/20 0.32
GPR3 P46089 1/20 0.31
POLB P06746 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP2C19 P33261 1/20 0.31
IDO1 P14902 1/20 0.30
ALDH1A1 P00352 1/20 0.30
TUBB4A P04350 1/20 0.30
TUBB P07437 1/20 0.30
TUBA3C P0DPH7 1/20 0.30
TUBA1B P68363 1/20 0.30
TUBA4A P68366 1/20 0.30
TUBB4B P68371 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20926819 0.88 KDM4E (0.46) KDM4EATML3MBTL1CYP1A2CYP2C19
SCHEMBL22929930 0.87 MEN1 (0.34) ATML3MBTL1DUSP3CDK5CDK5R1
SCHEMBL20926824 0.87 KDM4E (0.45) KDM4EATML3MBTL1CYP1A2CYP2C19
SCHEMBL24120825 0.85 KDM4E (0.32) KDM4EATML3MBTL1DUSP3CDK5
SCHEMBL20926810 0.85 KDM4E (0.42) KDM4EATML3MBTL1CYP1A2CYP2C19
SCHEMBL20926812 0.85 KDM4E (0.42) KDM4EATML3MBTL1DUSP3CYP1A2
SCHEMBL22930041 0.84 KDM4E (0.30) KDM4EATML3MBTL1
SCHEMBL20926787 0.83 KDM4E (0.39) KDM4EATML3MBTL1CYP1A2CYP2C19
SCHEMBL20926859 0.83 GPR3 (0.32) L3MBTL1GPR3POLBALDH1A1
SCHEMBL20926860 0.83 AHR (0.34) KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10910577-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2021-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10910577-B2 Organic electroluminescent materials and devices CACNA2D2, ORC3, ANO2 KDM4E 1899/4885ATM 4018/4885L3MBTL1 1530/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.